CALIXAR provides high-quality membrane protein identification services for scientists and researchers who need to explain the mechanisms of specific ligands in native environments, and or to identify new membrane protein markers of specific diseases or pathologies.
CALIXAR’s membrane protein identification services assist our clients in producing information regarding:
Unlike conventional approaches that would alter the native interaction between target/ligand or target/hits or target/lead compound, target/partner complexes, CALIXAR’s approach permits the preservation of the functional and structural integrity of these complexes.
This has a significantly positive result on the quality and reliability of the data from target validation studies and preclinical to clinical studies.
Our technological platform helps to generate reliable hits/leads with better chances to succeed in during the entire drug discovery and clinical stages.
Our native approach enables to identify new antigens/targets/markers for specific diseases and pathologies.
If you find yourself in one of the following discovery or clinical stages, CALIXAR’s Membrane Protein identification services are ideal for you:
Our linked strategy ensures compatibility with many different applications and in particular the identification of targets/ligands and the understanding of the mechanism of action.
We can control protein-protein interactions in the native environment and thus enables our clients to generate highly relevant and reliable information about membrane proteins.
The CALIXAR® platform employs patented technology only accessible to clients under various flexible business modalities (license, co-development, and service).
You can leverage CALIXAR’s exclusive technology as well as other best-in-class membrane protein technology not accessible anyplace else on the market today.